Target intelligence / Profile preview

Ubiquitin-conjugating enzyme E2 L5 (UBE2L5)

Target
UBE2L5
Molecular classification
Enzyme, Ubiquitin-conjugating enzyme, E2 enzyme, Protein modifier
01

Overview

Ubiquitin-conjugating enzyme E2 L5 (UBE2L5) is a member of the E2 family of enzymes, which play a central role in the ubiquitination pathway. UBE2L5 catalyzes the transfer of ubiquitin from E1 (activating enzymes) to substrate proteins, usually in concert with an E3 (ligase), marking them for proteasomal degradation or altering their cellular function. This enzyme is predicted to participate in K11-linked ubiquitination and is primarily active in the nucleus. An important paralog is UBE2L3. UBE2L5 is part of the overall ubiquitin-proteasome system that regulates protein turnover and quality control in cells. There are no well-documented direct disease roles, interacting drugs, or safety concerns specifically associated with UBE2L5 as of current knowledge.

Other names
UBE2L5Ubiquitin-protein ligase L5UBCH7N2UBE2L5Pubiquitin-conjugating enzyme E2 L5ubiquitin-protein ligase L5
02

Mechanism of action

Conjugation of ubiquitin to substrate proteins (via interaction with E1 and E3 enzymes)

03

Biological functions

UbiquitinationProtein catabolic processProtein quality controlRegulation of protein degradation
04

Disease associations

Other (no direct association with major disease categories has been reported)

Beyond the preview

Go deeper on Ubiquitin-conjugating enzyme E2 L5 (UBE2L5).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ubiquitin-conjugating enzyme E2 L5 (UBE2L5).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call